EGM
SWTX

Engineers Gate Manager’s SpringWorks Therapeutics SWTX Stock Holding History

Engineers Gate Manager’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,733
Closed -$341K – 2525
2025
Q1 		$341K Buy
+7,733
New +$356K 0.01% 1641
2024
Q4 		– Sell
-29,303
Closed -$939K – 2562
2024
Q3 		$939K Buy
29,303
+11,061
+61% +$413K 0.02% 1031
2024
Q2 		$687K Buy
18,242
+1,755
+11% +$73.9K 0.02% 1073
2024
Q1 		$811K Buy
+16,487
New +$762K 0.02% 945
2023
Q4 		– Sell
-28,178
Closed -$651K – 2252
2023
Q3 		$651K Buy
28,178
+19,952
+243% +$546K 0.02% 930
2023
Q2 		$216K Sell
8,226
-8,529
-51% -$224K 0.01% 1447
2023
Q1 		$431K Buy
+16,755
New +$490K 0.02% 1051
2022
Q1 		– Sell
-9,257
Closed -$574K – 2295
2021
Q4 		$574K Buy
9,257
+5,926
+178% +$392K 0.03% 963
2021
Q3 		$211K Sell
3,331
-10,873
-77% -$838K 0.01% 1411
2021
Q2 		$1.17M Buy
+14,204
New +$1.08M 0.08% 362

Other funds holding SWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Engineers Gate Manager's SWTX Position: Q2 2025 in Review

Engineers Gate Manager sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 7,733 shares — an estimated $341K sold.

Engineers Gate Manager first reported a position in SWTX in Q2 2021 and held it in 10 quarters. The position peaked at $1.17M in Q2 2021. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Engineers Gate Manager reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 7,733 SpringWorks Therapeutics shares in Q2 2025, an estimated $341K.
  • Engineers Gate Manager first reported a position in SpringWorks Therapeutics in Q2 2021 and held it in 10 quarters.
  • Engineers Gate Manager's SpringWorks Therapeutics position peaked at $1.17M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Engineers Gate Manager's 13F filing for Q2 2025, filed 14 Aug 2025.